Janssen gets USFDA nod for psoriatic arthritis treatment STELARA for pediatric patients Ruchika Sharma4 Aug 2022 11:46 AM ISTSTELARA is administered as a subcutaneous injection dosed four times per year after two starter doses for the treatment of pediatric patients six...
Janssen Pharma gets USFDA Breakthrough Therapy Designation for Multiple Myeloma treatment Talquetamab Ruchika Sharma30 Jun 2022 3:02 PM ISTTalquetamab is an investigational, off-the-shelf, T-cell redirecting bispecific antibody targeting both GPRC5D, a novel drug target, on multiple...
Phase 3 SHINE results show postive results for IMBRUVICA (ibrutinib) in Mantle Cell Lymphoma Ruchika Sharma5 Jun 2022 3:00 PM ISTMCL is a type of aggressive, rare non-Hodgkin lymphoma (NHL) that is incurable and difficult to treat.
Janssen Pharma launches icare4u program for skin, joint, digestive disorders Ruchika Sharma22 May 2022 9:00 AM ISTMumbai: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the launch of icare4u, a comprehensive program to support the...
USFDA extends review for JnJ, Legend CAR-T therapy cilta-cel Ruchika Sharma6 Nov 2021 9:00 AM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has recently announced that the U.S. Food and Drug Administration (FDA) has...
Janssen Pharma Selexipag gets USFDA nod to treat pulmonary arterial hypertension Ruchika Sharma2 Aug 2021 12:15 PM ISTTitusville: The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced that the U.S. Food and Drug Administration (FDA) has...
Janssen Covid-19 vaccine under EU review over blood clots reports Ruchika Sharma10 April 2021 5:12 PM ISTBrussels: Europe's medicines watchdog said it was reviewing reports of rare blood clots in four people who received the Covid-19 vaccine developed by...
Cidara Therapeutics, Janssen Pharma collaborate to develop, commercialize AVCs for influenza Ruchika Sharma6 April 2021 1:50 PM ISTSan Diego: Cidara Therapeutics, Inc., a biotechnology company developing long-acting therapeutics designed to transform the standard of care for...
Johnson and Johnson expands COVID-19 vaccine trial to include adolescents Ruchika Sharma4 April 2021 11:00 AM ISTNew Brunswick: Johnson & Johnson has recently announced that the company has begun vaccinating adolescent participants in the ongoing Phase...
Janssen gets positive CHMP opinion for Ponvory for treating relapsing forms of multiple sclerosis in adults Ruchika Sharma29 March 2021 10:00 AM ISTBelgium: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced that the European Medicines Agency's (EMA) Committee for...
Janssen Pharma gets USFDA nod for Ponvory to treat relapsing multiple sclerosis Ruchika Sharma21 March 2021 10:15 AM ISTNew Jersy: The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (USFDA) approved PONVORY...
WHO grants Emergency Use Listing to JnJ Single-Shot COVID-19 vaccine Ruchika Sharma13 March 2021 12:38 PM ISTThe Johnson & Johnson COVID-19 single-shot vaccine is compatible with standard vaccine storage and distribution channels enabling delivery to remote...
